Chaired by Dr. Brooks Cash, Chief of Gastroenterology and Hepatology at the University of Texas Health Center at Houston Scientific Advisory Board to guide on programs to screen and test patients in US and other countries where colorectal cancer screening… Read More
News
Biomerica Receives Notice of Allowance from Canadian Patent Office for Patent Covering Irritable Bowel Syndrome (IBS) Food Sensitivity Testing & Treatment
Studies show that 13-20% of Canadians suffer from IBS at any given time 1 . The lifetime risk for a Canadian to develop IBS is 30% 1 . IRVINE, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) — Biomerica, Inc. (NASDAQ: BMRA) today announced that the Canadian… Read More
Biomerica Launches New Website for Its Aware® Breast Exam Device
Simple at-home breast exam device provides results within minutes Studies show increase in Breast Exam Sensitivity IRVINE, Calif. , Oct. 29, 2021 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that in conjunction with Breast Cancer Awareness… Read More
Walmart to Begin Nationwide In-Store Sales of Biomerica’s EZ Detect™ Colorectal Screening Test
Over 4,600 Walmart Stores to sell the EZ Detect™ product Simple 2 minute at-home test detects early warning sign of colorectal cancer IRVINE, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that Walmart has… Read More
Biomerica Signs Exclusive Distribution Agreement in Canada for its New and Proprietary Helicobacter Pylori (H. pylori) Test, hp+detect™
Prevalence of H. pylori infection in the United States is approximately 35% to 40% of the population IRVINE, Calif., June 24, 2021 (GLOBE NEWSWIRE) — Biomerica Inc. (NASDAQ: BMRA) today announced that it has signed an exclusive five-year distribution agreement with a… Read More
Biomerica Receives Notice of Allowance from Mexican Patent Office for Irritable Bowel Syndrome Food Sensitivity Testing & Treatment
IBS is one of the most important gastrointestinal disorders in Mexico, with a prevalence of around 16% [ 1 ] (approximately 20 million patients) Broadens InFoods global patent coverage with recently allowed patents in Korea and Japan IRVINE, Calif., June 15, 2021 (GLOBE NEWSWIRE) —… Read More